- Trials with a EudraCT protocol (33)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
33 result(s) found for: cluster headache.
Displaying page 1 of 2.
EudraCT Number: 2015-004436-34 | Sponsor Protocol Number: CSOM230Y2201 | Start Date*: 2017-02-06 | ||||||||||||||||
Sponsor Name:Novartis Pharma AG | ||||||||||||||||||
Full Title: A Multicenter, Placebo-Controlled, Single Dose Study in Acute Episodic and Chronic Cluster Headache to Evaluate the Safety and Efficacy of SOM230 subcutaneous (s.c.) | ||||||||||||||||||
Medical condition: Cluster headache | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-004999-36 | Sponsor Protocol Number: BCBe/04/FRO-CLU/001 | Start Date*: 2006-11-06 | |||||||||||
Sponsor Name:Berlin-Chemie AG | |||||||||||||
Full Title: Effects of Frovatriptan as Prophylactic Treatment of Cluster Headache, a Multi-Center, Placebo Controlled, Randomized, Double-Blind Prospective Phase III Parallel-Group Trial Comparing Frovatriptan... | |||||||||||||
Medical condition: Episodic cluster headache | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000149-22 | Sponsor Protocol Number: I5Q-MC-CGAL | Start Date*: 2015-07-02 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Episodic Cluster Headache | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) DK (Completed) BE (Completed) FI (Completed) ES (Completed) NL (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000248-91 | Sponsor Protocol Number: BTACH2012 | Start Date*: 2013-01-08 | |||||||||||
Sponsor Name:Institutt for nevromedisin, NTNU | |||||||||||||
Full Title: Endoscopic block of the sphenopalatine ganglion with botulinum toxin in intractable cluster headache. Safety issues. | |||||||||||||
Medical condition: Pharmacological refractory cluster headache with durations of periods of attacks normally more than 2 months | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005429-11 | Sponsor Protocol Number: I5Q-MC-CGAM | Start Date*: 2015-07-14 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 with a Long-Term Open-Label Extension in Patients with Chronic Cluster Headache | |||||||||||||
Medical condition: Chronic Cluster Headache | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) ES (Completed) DK (Completed) FI (Completed) BE (Completed) FR (Completed) NL (Completed) GR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006204-13 | Sponsor Protocol Number: PredCH | Start Date*: 2013-01-17 | |||||||||||
Sponsor Name:University of Duisburg-Essen | |||||||||||||
Full Title: Efficacy and safety of oral prednisone as add-on therapy in the prophylactic treatment of episodic cluster headache: a randomized, placebo controlled parallel study. | |||||||||||||
Medical condition: Episodic Cluster Headache (ECH) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004399-16 | Sponsor Protocol Number: CHERUB01 | Start Date*: 2021-04-28 | |||||||||||
Sponsor Name:Charité - Universitätsmedizin Berlin | |||||||||||||
Full Title: Efficacy of erenumab in chronic cluster headache: A 10-week double-blind, randomized, placebo-controlled, multicentric trial | |||||||||||||
Medical condition: chronic cluster headache | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019058-42 | Sponsor Protocol Number: LITIO-SUM-FC-002 | Start Date*: 2010-05-26 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO UNIVERSITARIA DI CAGLIARI | |||||||||||||
Full Title: Safety of sumatriptan in combination with lithium for treatment of cluster headache, Pilot Study,Phase II | |||||||||||||
Medical condition: Cluster Headache | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005234-21 | Sponsor Protocol Number: I5Q-MC-CGAR | Start Date*: 2016-10-13 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Phase 3b Multicenter, Single-Arm, Open-Label Safety Study of LY2951742 (galcanezumab) in Patients with Episodic or Chronic Cluster Headache | |||||||||||||
Medical condition: Episodic Cluster Headache, Chronic Cluster Headache | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) FI (Completed) ES (Completed) DK (Completed) NL (Completed) GR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001968-28 | Sponsor Protocol Number: 19385A | Start Date*: 2022-02-24 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: Interventional, open-label, fixed-dose multiple administration study to evaluate long-term treatment with eptinezumab in patients with chronic cluster headache | |||||||||||||
Medical condition: Chronic cluster headache | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) DK (Completed) NL (Completed) FI (Completed) ES (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003729-62 | Sponsor Protocol Number: R-Verapamil-001 | Start Date*: 2013-01-16 | |||||||||||
Sponsor Name:CENTER LABORATORIES, INC | |||||||||||||
Full Title: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of R-Verapamil in the Prophylaxis of Episodic Cluster Headache | |||||||||||||
Medical condition: Episodic Cluster Headache | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002737-39 | Sponsor Protocol Number: | Start Date*: 2005-06-14 |
Sponsor Name:National Headache Institute | ||
Full Title: Prophylactic treatment of episodic cluster headache with an angiotensin II receptor blocker (candesartan cilexetil); a randomized, placebo controlled parallel study. | ||
Medical condition: Episodic cluster headache | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: DK (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004213-28 | Sponsor Protocol Number: OTOBLOCKCH2016 | Start Date*: 2017-03-14 |
Sponsor Name:Department of Neuroscience, NTNU | ||
Full Title: Botulinum toxin type A block of the otic ganglion in chronic cluster headache. Safety issues. | ||
Medical condition: Cluster headache | ||
Disease: | ||
Population Age: Elderly | Gender: | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001969-37 | Sponsor Protocol Number: 19386A | Start Date*: 2021-03-05 | |||||||||||
Sponsor Name:H. Lundbeck A/S | |||||||||||||
Full Title: Interventional, randomized, double-blind, parallel-group, placebo-controlled delayed-start study to evaluate the efficacy and safety of eptinezumab in patients with episodic Cluster Headache | |||||||||||||
Medical condition: Episodic cluster headache | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Prematurely Ended) DK (Prematurely Ended) DE (Prematurely Ended) SE (Prematurely Ended) CZ (Completed) PT (Prematurely Ended) FR (Prematurely Ended) BE (Completed) NL (Prematurely Ended) FI (Completed) GR (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003148-21 | Sponsor Protocol Number: BASICstudy | Start Date*: 2019-01-25 |
Sponsor Name:NTNU- Norwegian University of Science and Technology | ||
Full Title: BASIC - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic cluster headache | ||
Medical condition: Chronic cluster headache | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) DE (Ongoing) ES (Ongoing) IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006687-25 | Sponsor Protocol Number: 79665 | Start Date*: 2022-07-21 |
Sponsor Name:Leiden University Medical Centre | ||
Full Title: Repeated corticosteroid injections around the Greater Occipital Nerve (GON) as prophylactic treatment in chronic cluster headache | ||
Medical condition: Chronic Cluster headache | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003648-59 | Sponsor Protocol Number: CH1.0 | Start Date*: 2012-10-01 |
Sponsor Name:Dept. of Neurology, Atrium Medical Centre | ||
Full Title: Oxygen treatment for cluster headache attacks at different flow rates. A double-blind, randomized, cross-over design study. | ||
Medical condition: To study whether there is a difference in treatment effect between oxygen at flow rates of 7 L/min versus 12 L/min in the acute treatment of cluster headache attacks. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003382-34 | Sponsor Protocol Number: NeuroPharm_EPOCH | Start Date*: 2019-06-17 | |||||||||||||||||||||
Sponsor Name:NeuroPharm | |||||||||||||||||||||||
Full Title: Prophylactic effects of psilocybin on chronic cluster headache: an open-label clinical trial and neuroimaging study. | |||||||||||||||||||||||
Medical condition: Chronic cluster headache. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-002224-17 | Sponsor Protocol Number: 201805GON | Start Date*: 2019-05-07 |
Sponsor Name:Leids Universitair Medisch Centrum | ||
Full Title: GON-injection for a sooner and better treatment of cluster headache: a double-blind randomized controlled trial | ||
Medical condition: Episodic cluster headache | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001260-29 | Sponsor Protocol Number: CCH01 | Start Date*: 2019-09-10 | |||||||||||
Sponsor Name:CCH Pharmaceuticals | |||||||||||||
Full Title: Proof of concept study for evaluation of the effect of ketamine intranasal spray in treatment of chronic Cluster Headache (CCH) | |||||||||||||
Medical condition: Chronic Cluster Headache | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.